Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator instructions] I would now like to turn the conference over to your host, Mike Czapar, ...
Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and ...
Reuters on MSN15d
Lilly needs a plan to spur weight-loss drug sales, investors say(Reuters) - Eli Lilly investors and analysts said they want to hear details ... Lilly Chief Financial Officer Lucas Montarce told Reuters last month the drugmaker is trying to balance its ...
INDIANAPOLIS, Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO ...
David Ricks; Chairman of the Board, President, Chief Executive Officer; Eli Lilly and Co Lucas Montarce; Executive Vice President and Chief Financial Officer; Eli Lilly and Co Daniel Skovronsky; Chief ...
"so that's what we built in our 2025 guidance for the market," the company's CFO Lucas Montarce said during an earnings call on Thursday. Shares of Eli Lilly rose more than 4% on Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback